China (Mainland)
High purity pharmaceutical raw material Flibanserin CAS NO.167933-07-5
- FOB Price: USD: 1,000.00-1,050.00 /Kilogram Get Latest Price
- Min.Order: 1 Kilogram
- Payment Terms: T/T
- Available Specifications:
Pharmaceutical Grade(1-50)KilogramPharmaceutical Grade(50-500)Kilogram
- Product Details
Keywords
- Flibanserin
- Bimt 17
- HSDD
Quick Details
- ProName: High purity pharmaceutical raw materia...
- CasNo: 167933-07-5
- Appearance: white powder
- Application: weight manage raw material
- DeliveryTime: 3days
- PackAge: 1kg per bag
- Port: Guangzhou, China
- ProductionCapacity: 1000 Kilogram/Month
- Purity: 99.5%
- Storage: Sealed storage
- Transportation: standard packaging
- LimitNum: 1 Kilogram
- Related Substances: 0.48%
- Residue on Ignition: 0.05%
- Heavy Metal: 0.1%
- Valid Period: two years
Superiority
About us:
Guangzhou Trojan Pharmatec Ltd. (“Trojan”), founded in 2013, is a
high-tech company of personal care functional ingredients, APIs
and pharmaceutical intermediates in China.
With a leading professional R & D team and well trained workers,
Trojan has a R&D facility of 1,100 square meters in Guangzhou
Science City and possess two manufacturing sites in Guangzhou
and Shaoguan. Our factory has more than 50 sets of 200L-3000L
reactors.
Since the establishment, trojan has made progress on a number of
projects and some of which has be put into production. We have
attained two china invention patents and filed a Chinese invention
patent so far. With the spirit of “working together to achieve
perfection” the company aims to become a leading domestic
pharmaceutical enterprise with competitiveness.
Name: Flibanserin
CAS No.: 167933-07-5
Molecular formula: C20H21F3N4O
Molecular weight: 390.40200
Appearance: white powder
Purity： 99.5%
Packing: Foil bag （1kg/bag;25kg/drum）
Delivery： in stock
Flibanserin (code: BIMT-17), trade name Addyi, was found to be a drug used to treat sexual desire disorder (HSDD) in premenopausal women. Flibanserin was developed by Boehringer Ingelheim, but was negatively evaluated by the US Food and Drug Administration (FDA) in October 2010. Subsequently, the pharmaceutical rights were handed over to the germinated pharmaceutical (en:Sprout Pharmaceuticals) for further research and development, and in August 2015, the US Food and Drug Administration approved. Flibanserin can be increased by 0.5-1 times on a 2-3-time satisfactory sexual behavior in one month compared to placebo.
Details
Name: Flibanserin
CAS No.: 167933-07-5
Molecular formula: C20H21F3N4O
Molecular weight: 390.40200
Appearance: white powder
Purity： 99.5%
Packing: Foil bag （1kg/bag;25kg/drum）
Delivery： in stock
Flibanserin (code: BIMT-17), trade name Addyi, was found to be a drug used to treat sexual desire disorder (HSDD) in premenopausal women. Flibanserin was developed by Boehringer Ingelheim, but was negatively evaluated by the US Food and Drug Administration (FDA) in October 2010. Subsequently, the pharmaceutical rights were handed over to the germinated pharmaceutical (en:Sprout Pharmaceuticals) for further research and development, and in August 2015, the US Food and Drug Administration approved. Flibanserin can be increased by 0.5-1 times on a 2-3-time satisfactory sexual behavior in one month compared to placebo.
